Tamoxifen is the gold standard for endocrine treatment of estrogen-receptor positive breast cancer. Tamoxifen is also known to have metabolic effects. A new study reports that the drug also prevents ...

The Continent Professor Collen Masimirembwa deservedly won this year’s African Genius Award. The pharmacogenetics pioneer has ...

Summary Affected products Unauthorized seized health products, including: Issue Health Canada is warning consumers about multiple unauthorized drug products seized ...

As though battling cancer wasn't enough of a struggle, Sally was simultaneously dealing with a spinal bulge diagnosis that ...

Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is conducting a Phase 2 ...

Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies such as tamoxifen. Recurrence is also ...

As of Wednesday, December 31, Atossa Therapeutics, Inc.’s ATOS share price has dipped by 9.72%, which has investors ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

Look at the area from your armpit, across and beneath your boobs, pecs or chest, and up to your collarbone. Be aware of any changes in size, outline or shape and changes in skin such as puckering or ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, ...

Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.

Antigen-driven TCR signaling in the epidermis during CD8+ TRM differentiation results in a lower TGFβ requirement for persistence and increased proliferative capacity that together enhance epidermal ...